[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Degenerative Disc Disease Treatment Market Size study & Forecast, by Type (Conventional Drugs, Novel Therapies) by End-user (Hospitals, Clinics, Others) and Regional Analysis, 2022-2029

February 2023 | 200 pages | ID: G4250F9D48B2EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Degenerative Disc Disease Treatment Market is valued at approximately USD 26.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Degenerative disc disease (DDD) is a medical condition that results in the degeneration of one or more discs between the vertebrae of the spinal column. In that condition, the injured spinal disc leads patients to have chronic low back discomfort and potentially causes long-term impairment. the treatment involves muscle relaxers, pain relief medications, steroids, and Non-steroidal Anti-inflammatory Drugs (NSAIDs). The growing availability of both non-surgical and spinal fusion process, rising clinical approvals, and increasing healthcare expenditure are some chief factors that are surging the market demand in the global market.

The rising prevalence of chronic lower back pain is bolstering the need for degenerative disc disease therapy among the population, especially among senior people. For instance, the International Association for the Study of Pain published statistics from 2021 that predicted the point prevalence of low back pain (LBP) to be around 7.5% of the world's population. Similarly, a 2021 article from the National Centers for Biotechnology Information (NCBI) reported that the prevalence of disc degeneration was 12.4% in the population between the ages of 18 and 29 and soared to 98.2% in those between the ages of 60 and 69. Therefore, these aforementioned factors are stipulating the market growth across the globe. Moreover, the rising launch of innovative and technologically advanced products, as well as the growing R&D investments are presenting various lucrative opportunities over the forecasting years. However, limited availability of effective drugs and novel therapies for the treatment of this condition and presence of alternative therapies are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Degenerative Disc Disease Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing adoption of drugs and treatments among the patient population, along with the rising prevalence of the condition, Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the surging demand for the drugs for various treatment, escalating target population, as well as increasing diagnosis of the condition in the market space.

Major market players included in this report are:
B. Braun Melsungen AG
Pfizer Inc.
Novartis AG
Eli Lilly and Company
DiscGenics, Inc.
Spine BioPharma
FibroGenesis
Ferring B.V.
Globus Medical
Paradigm Spine LLC

Recent Developments in the Market:
In March 2022, Pfizer Inc. announced the acquisition of Arena- a clinical-stage company developing innovative potential therapies to cure immuno-inflammatory diseases. The primary objective of this initiative is the strengthening of the product portfolio.
In December 2021, Teva Pharmaceutical Industries Ltd. declared the introduction of Ibuprofen 800 mg tablets, the generic version of Duexis, indicated for pain management in the U.S., which aims to boost the company’s product portfolio.

Global Degenerative Disc Disease Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Conventional Drugs
Novel Therapies
By End-user:
Hospitals
Clinics
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  1.2.1. Degenerative Disc Disease Treatment Market, by Region, 2019-2029 (USD Billion)
  1.2.2. Degenerative Disc Disease Treatment Market, by Type, 2019-2029 (USD Billion)
  1.2.3. Degenerative Disc Disease Treatment Market, by End-user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL DEGENERATIVE DISC DISEASE TREATMENT MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL DEGENERATIVE DISC DISEASE TREATMENT MARKET DYNAMICS

3.1. Degenerative Disc Disease Treatment Market Impact Analysis (2019-2029)
  3.1.1. Market Drivers
    3.1.1.1. Rising prevalence of chronic lower back pain and degenerative disc disease
    3.1.1.2. Growing availability of both non-surgical and spinal fusion process
  3.1.2. Market Challenges
    3.1.2.1. Limited availability of effective drugs and novel therapies for the treatment of this condition
    3.1.2.2. Presence of alternative therapies
  3.1.3. Market Opportunities
    3.1.3.1. Rising launch of innovative and technologically advanced products
    3.1.3.2. Growing R&D investments

CHAPTER 4. GLOBAL DEGENERATIVE DISC DISEASE TREATMENT MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
  4.3.1. Political
  4.3.2. Economical
  4.3.3. Social
  4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

CHAPTER 6. GLOBAL DEGENERATIVE DISC DISEASE TREATMENT MARKET, BY TYPE

6.1. Market Snapshot
6.2. Global Degenerative Disc Disease Treatment Market by Type, Performance - Potential Analysis
6.3. Global Degenerative Disc Disease Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Degenerative Disc Disease Treatment Market, Sub Segment Analysis
  6.4.1. Conventional Drugs
  6.4.2. Novel Therapies

CHAPTER 7. GLOBAL DEGENERATIVE DISC DISEASE TREATMENT MARKET, BY END-USER

7.1. Market Snapshot
7.2. Global Degenerative Disc Disease Treatment Market by End-user, Performance - Potential Analysis
7.3. Global Degenerative Disc Disease Treatment Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
7.4. Degenerative Disc Disease Treatment Market, Sub Segment Analysis
  7.4.1. Hospitals
  7.4.2. Clinics
  7.4.3. Others

CHAPTER 8. GLOBAL DEGENERATIVE DISC DISEASE TREATMENT MARKET, REGIONAL ANALYSIS

8.1. Degenerative Disc Disease Treatment Market, Regional Market Snapshot
8.2. North America Degenerative Disc Disease Treatment Market
  8.2.1. U.S. Degenerative Disc Disease Treatment Market
    8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    8.2.1.2. End-user breakdown estimates & forecasts, 2019-2029
  8.2.2. Canada Degenerative Disc Disease Treatment Market
8.3. Europe Degenerative Disc Disease Treatment Market Snapshot
  8.3.1. U.K. Degenerative Disc Disease Treatment Market
  8.3.2. Germany Degenerative Disc Disease Treatment Market
  8.3.3. France Degenerative Disc Disease Treatment Market
  8.3.4. Spain Degenerative Disc Disease Treatment Market
  8.3.5. Italy Degenerative Disc Disease Treatment Market
  8.3.6. Rest of Europe Degenerative Disc Disease Treatment Market
8.4. Asia-Pacific Degenerative Disc Disease Treatment Market Snapshot
  8.4.1. China Degenerative Disc Disease Treatment Market
  8.4.2. India Degenerative Disc Disease Treatment Market
  8.4.3. Japan Degenerative Disc Disease Treatment Market
  8.4.4. Australia Degenerative Disc Disease Treatment Market
  8.4.5. South Korea Degenerative Disc Disease Treatment Market
  8.4.6. Rest of Asia Pacific Degenerative Disc Disease Treatment Market
8.5. Latin America Degenerative Disc Disease Treatment Market Snapshot
  8.5.1. Brazil Degenerative Disc Disease Treatment Market
  8.5.2. Mexico Degenerative Disc Disease Treatment Market
  8.5.3. Rest of Latin America Degenerative Disc Disease Treatment Market
8.6. Rest of The World Degenerative Disc Disease Treatment Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. B. Braun Melsungen AG
    9.2.1.1. Key Information
    9.2.1.2. Overview
    9.2.1.3. Financial (Subject to Data Availability)
    9.2.1.4. Product Summary
    9.2.1.5. Recent Developments
  9.2.2. Pfizer Inc.
  9.2.3. Novartis AG
  9.2.4. Eli Lilly and Company
  9.2.5. DiscGenics, Inc.
  9.2.6. Spine BioPharma
  9.2.7. FibroGenesis
  9.2.8. Ferring B.V.
  9.2.9. Globus Medical
  9.2.10. Paradigm Spine LLC

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Degenerative Disc Disease Treatment Market, report scope
TABLE 2. Global Degenerative Disc Disease Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Degenerative Disc Disease Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Degenerative Disc Disease Treatment Market estimates & forecasts by End-user 2019-2029 (USD Billion)
TABLE 5. Global Degenerative Disc Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Degenerative Disc Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Degenerative Disc Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Degenerative Disc Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Degenerative Disc Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Degenerative Disc Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Degenerative Disc Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Degenerative Disc Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Degenerative Disc Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Degenerative Disc Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Degenerative Disc Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Degenerative Disc Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Degenerative Disc Disease Treatment Market
TABLE 70. List of primary sources, used in the study of global Degenerative Disc Disease Treatment Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Degenerative Disc Disease Treatment Market, research methodology
FIG 2. Global Degenerative Disc Disease Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Degenerative Disc Disease Treatment Market, key trends 2021
FIG 5. Global Degenerative Disc Disease Treatment Market, growth prospects 2022-2029
FIG 6. Global Degenerative Disc Disease Treatment Market, porters 5 force model
FIG 7. Global Degenerative Disc Disease Treatment Market, pest analysis
FIG 8. Global Degenerative Disc Disease Treatment Market, value chain analysis
FIG 9. Global Degenerative Disc Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Degenerative Disc Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Degenerative Disc Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Degenerative Disc Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Degenerative Disc Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Degenerative Disc Disease Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Degenerative Disc Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Degenerative Disc Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Degenerative Disc Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Degenerative Disc Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Degenerative Disc Disease Treatment Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable


More Publications